The objective of this study is to evaluate effectiveness and safety of GENOUS EPC-coated stent in patients with STEMI with other drug-eluting stents (DESs).
This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of GENOUS stent in STEMI patients with other-type DESs.
Study Type
OBSERVATIONAL
Enrollment
464
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
Kangwon National University Hospital
Chuncheon, South Korea
Daegu Catholic University Medical Center
composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target- Vessel Revascularization (TVR)
Time frame: 12 months post procedure
Death (all cause and cardiac)
Time frame: one month
Death (all cause and cardiac)
Time frame: 6 months
Death (all cause and cardiac)
Time frame: yearly up to 5 years
MI
Time frame: one month
MI
Time frame: 6 months
MI
Time frame: yearly up to 5 years
Composite of death or MI
Time frame: one month
Composite of death or MI
Time frame: 6 months
Composite of death or MI
Time frame: yearly up to 5 years
Composite of cardiac death or MI
Time frame: one month
Composite of cardiac death or MI
Time frame: 6 months
Composite of cardiac death or MI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Konyang University Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Chonnam National University Hospital
Gwangju, South Korea
National Health Insurance Corporation Ilsan Hospital
Ilsan, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Inha University Hospital
Incheon, South Korea
...and 6 more locations
Time frame: yearly up to 5 years
TVR
Time frame: one month
TVR
Time frame: 6 months
TVR
Time frame: yearly up to 5 years
Target-lesion revascularization (TLR)
Time frame: yearly up to 5 years
Target-lesion revascularization (TLR)
Time frame: one month
Target-lesion revascularization (TLR)
Time frame: 6 months
Stent thrombosis (ARC criteria)
Time frame: one month
Stent thrombosis (ARC criteria)
Time frame: 6 months
Stent thrombosis (ARC criteria)
Time frame: yearly up to 5 years
Procedural success (defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization)
Time frame: in-hospital